Ashley Hinson’s Record on Water Pollution Faces Scrutiny in Senate Run
May 4, 2026
Iowa Rep. Ashley Hinson, now a U.S. Senate candidate, faces scrutiny over her votes to loosen clean water rules, impacting PFAS exposure.
Iowa Rep. Ashley Hinson, now a U.S. Senate candidate, faces scrutiny over her votes to loosen clean water rules, impacting PFAS exposure.
Subscribe to our newsletter for the latest updates! Manage your preferences with ease and never miss out on important news and insights.
Tennessee Rep. Andy Ogles hired a firm linked to Darian Rafie, known for using geospatial tech to track rallygoers’ phones for data collection.
Jonathan Bush, Maine governor candidate, likens Medicaid expansion to Putin’s actions in Ukraine, sparking controversy in the Republican primary.
Maine Sen. Susan Collins, despite leading the Senate Appropriations Committee, hasn’t called for an investigation into the White House’s actions in Iran or its withholding of federal funds. Collins, who once emphasized Congress’s “power of the purse,” now faces criticism for inaction amidst a billion-dollar daily war expenditure.
Newly discovered posts reveal Pennsylvania Treasurer Stacy Garrity’s support for Jan. 6 rioters, raising questions about her past views.
JoAnna Mendoza, former Marine and single mother, campaigns to unseat Rep. Juan Ciscomani, emphasizing servant leadership and addressing local issues.
John James and Aric Nesbitt, GOP candidates for Michigan governor, claim the 2020 election was stolen from Trump, citing voter fraud.
Democrat Janelle Stelson, a former Emmy-winning TV anchor, is challenging Trump ally Rep. Scott Perry in PA’s 10th Congressional District.
Republicans seeking to replace Arizona’s key officials have histories of supporting Trump’s baseless 2020 fraud claims.
Rick Jackson, a Georgia gubernatorial candidate, supports stricter abortion laws, taking credit for the state’s 6-week ban. A primary is set for May 19.
Carrie Buck, running for Congress in Nevada, campaigns on cost-cutting but opposed a bill to lower drug prices, citing concerns over price caps.
